RSLS News and Press, ReShape Lifesciences Inc. From 02/03/23

InvestorPlace - Stock Market News, Stock Advice & Trading Tips One of the biggest movers in today’s session,  Reshape Lifesciences  (NASDAQ: RSLS ) is absolutely skyrocketing. At the time of writing, RSLS stock has surged an impressive 150% in today’s session...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: metamorworks / Shutterstock MDxHealth (NASDAQ: MDXH ) stock is falling on Friday after the healthcare company revealed plans for a proposed public stock offering . With this offering, MDxHealth is seeking...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Shutterstock Edible Garden (NASDAQ: EDBL ) stock is falling hard on Friday as investors react to a proposed public stock offering . Edible Garden is planning a public offering that would see the company r...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Natali_ Mis/ShutterStock.com Genetic Technologies (NASDAQ: GENE ) stock is taking off on Friday as the company prepares for new cancer tests areas. The big news here is Genetic Technologies signing an agr...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Gorodenkoff / Shutterstock.com Reshape Lifesciences (NASDAQ: RSLS ) stock is rocketing higher on Friday as a filing mixup shines a light on the company’s shares. According to a filing with the U.S...

Health solutions company ReShape Lifesciences ( NASDAQ: RSLS ) rose by 4.20% after the company said its board has declared a 1-for-50 reverse stock split, effective from the commencement of trading on Dec. 23. Any fractional shares resulting from the reverse stock split is expecte...

SAN CLEMENTE, Calif., Dec. 22, 2022 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that its Board of Directors has declared a 1-for-50 reverse stock split of the company’s common st...

ReShape Lifesciences(TM) (NASDAQ: RSLS) is America's premier weight loss and metabolic health-solutions company, offering an integrated portfolio of proven products and services that manage and treat obesity and metabolic disease. The FDA-approved Lap-Band(R) Program provides minimally inv...

ReShape Lifesciences Inc. (RSLS) Q3 2022 Earnings Conference Call November 14, 2022 08:00 AM ET Company Participants Paula Schwartz - Managing Director-Rx Communications Group Paul Hickey - President & Chief Executive Officer Thomas Stankovich - Chief Financi...

ReShape Lifesciences ( NASDAQ: RSLS ) is scheduled to announce Q3 earnings results on Monday, November 14th, before market open. The consensus EPS Estimate is -$0.35 and the consensus Revenue Estimate is $3.62M (-2.2% Y/Y). Over the last 3 months, EPS estimates have se...